Molecular Profiling to Determine Clonality of Serial Magnetic Resonance Imaging/Ultrasound Fusion Biopsies From Men on Active Surveillance for Low-Risk Prostate Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-16-1454
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Magnetic Resonance Imaging for Predicting Prostate Biopsy Findings in Patients Considered for Active Surveillance of Clinically Low Risk Prostate Cancer

Journal of Urology
Urology
2012English

Multiparametric Magnetic Resonance Imaging and Ultrasound Fusion Biopsy Detect Prostate Cancer in Patients With Prior Negative Transrectal Ultrasound Biopsies

Journal of Urology
Urology
2012English

Magnetic Resonance Imaging-Ultrasound Fusion Biopsy for Prediction of Final Prostate Pathology

Journal of Urology
Urology
2014English

A Multiparametric Magnetic Resonance Imaging-Based Risk Model to Determine the Risk of Significant Prostate Cancer Prior to Biopsy

BJU International
Urology
2017English

Diagnostic Value of Guided Biopsies: Fusion and Cognitive-Registration Magnetic Resonance Imaging Versus Conventional Ultrasound Biopsy of the Prostate

Urology
Urology
2016English

V12-12 Office Based Magnetic Resonance Imaging-Ultrasound Fusion Guided Focal Cryotherapy of Prostate Cancer

Journal of Urology
Urology
2018English

Factors Predicting Prostate Cancer Upgrading on Magnetic Resonance Imaging-Targeted Biopsy in an Active Surveillance Population

Cancer
Cancer ResearchOncology
2017English

A Comparison of Magnetic Resonance Imaging Techniques Used to Secure Biopsies in Prostate Cancer Patients.

Expert Review of Anticancer Therapy
OncologyPharmacology
2019English

Why Men With a Low-Risk Prostate Cancer Select and Stay on Active Surveillance: A Qualitative Study

PLoS ONE
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy